Literature DB >> 7343705

An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis.

K D Nolph, F N Miller, W K Pyle, R P Popovich, M I Sorkin.   

Abstract

We present an hypothesis that could account for many characteristics of ultrafiltration and solute movement during peritoneal dialysis. The hypothesis describes transcapillary ultrafiltration and can account for (1) the osmotic effectiveness of rapidly absorbed glucose, (2) small solute sieving in a system permitting protein loss, (3) functional estimates of effective pore sizes as low as 11 A for urea and as high as 62 A for proteins from hydrodynamic analyses, (4) isolated loss of ultrafiltration without loss of clearance, (5) decreased ultrafiltration with decreased clearances, and (6) increased ultrafiltration with decreased clearances. Mechanisms for fluid movement from the peritoneal interstitium into the peritoneal cavity may involve both hydrostatic and osmotic pressure. Interstitial water pathway dimensions, interstitial gel surface charges, mesothelial cell surface charges, and transmesothelial-cell water movement might also account for sieving effects during peritoneal ultrafiltration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7343705     DOI: 10.1038/ki.1981.175

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  The effect of convection on bidirectional peritoneal solute transport: predictions from a distributed model.

Authors:  J K Leypoldt; L W Henderson
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

Review 2.  Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  T W Paton; W R Cornish; M A Manuel; B G Hardy
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

3.  Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.

Authors:  R A Mactier; R Khanna; Z Twardowski; H Moore; K D Nolph
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.